Brief: Baijin Life Science Expects FY Loss Of Up To HK$43 Million
29/06/2026 15:43
BRIEF-Baijin Life Science Expects FY Loss Of Up To HK$43 Million June 29 (Reuters) - Baijin Life Science Holdings Ltd 1466.HK:
EXPECTS LOSS OF UP TO HK$43 MILLION FOR YEAR ENDED 31 MARCH 2026
EXPECTED FY LOSS MAINLY DUE TO LOWER JEWELLERY REVENUE AND HIGHER SKINCARE SELLING EXPENSES
Further company coverage: 1466.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Baijin Life Science Holdings
See all newsBrief: Baijin Life Science Expects FY Loss Of Up To HK$43 Million
Brief: Baijin Life Science Says Unit Enters Strategic Cooperation Framework Agreement With Foryoung Biotechnology
Brief: Baijin Life Science Says Unit To Invest In Guhuan Medical For Sales Channel
Brief: Baijin Life Science Expects Net Profit Of HK$2.5 Million For HY
Brief: Baijin Life Science Says Beijing Baijin To Invest In Youhuan Bio For Circrna Platform